Blog
RSS FeedPosted by Michael Wonder on 09 May 2016
Cancer patient pays $5,000 every two weeks for treatment costing others just $6.20
9 May 2016 - At the age of 36, Danielle Tindle has been given an ultimatum — your money or your ...
Posted by Michael Wonder on 09 May 2016
Updated treatment algorithm for the treatment of HER2+ metastatic breast cancer
1 May 2016 - The PBAC treatment algorithm for anti-HER2 therapies for treating metastatic breast cancer has been updated to reflect ...
Posted by Michael Wonder on 07 May 2016
Pharmaceutical Benefits Advisory Committee Guidelines review
6 May 2016 - The public consultation processes on the draft revised PBAC Guidelines (Version 5.0) and the assessment of co-dependent ...
Posted by Michael Wonder on 04 May 2016
PBS expenditure and prescriptions report 2014-15
4 May 2016 - The PBS expenditure and prescriptions report 2014-15 is now available. ...
Posted by Michael Wonder on 02 May 2016
Cystic fibrosis patients campaign for drug Orkambi to be listed on Pharmaceutical Benefits Scheme
2 May 2016 - Without subsidy, it costs about US $260,000 each year. ...
Posted by Michael Wonder on 02 May 2016
Are the days of big pharma dominating the agenda of a PBAC meeting over?
2 May 2016 - The sponsor with the most number of submissions on the agenda for the next PBAC meeting ...
Posted by Michael Wonder on 02 May 2016
Post-market reviews of pulmonary arterial hypertension medicines and biological DMARDs to treat severe chronic plaque psoriasis
2 May 2016 - The public consultation process is now open for two PBAC post-market reviews. ...
Posted by Michael Wonder on 01 May 2016
Schedule of Pharmaceutical Benefits - 1 May 2016 update
1 May 2016 - The May 2016 issue of the Schedule sees a number of new and revised listings. ...
Posted by Michael Wonder on 29 Apr 2016
PBS listing of tamoxifen citrate projected to benefit thousands of women
29 April 2016 - Thousands of women will benefit from subsidised access to the breast cancer drug Tamoxifen which has been ...
Posted by Michael Wonder on 29 Apr 2016
Productivity Commission draft report on intellectual property arrangements
29 April 2016 - Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property ...
Posted by Michael Wonder on 29 Apr 2016
PBS and RPBS Section 85 date of processing and date of supply data
29 April 2016 - The PBS and RPBS Section 85 date of processing and date of supply data has now been ...
Posted by Michael Wonder on 28 Apr 2016
Big pharma gaming patents for extra cash: Productivity Commission
29 April 2016 - Global pharmaceutical giants are boosting revenues by unnecessarily extending patents in Australia, which is also slowing access ...
Posted by Michael Wonder on 28 Apr 2016
Anti-cancer drug Ribomustin added to PBS
28 April 2016 - Up to 30,000 Australians living with a slow-growing form of lymphoma could benefit from a new anti-cancer ...
Posted by Michael Wonder on 28 Apr 2016
Agenda for the July 2016 PBAC meeting
28 April 2016 - The agenda for the July 2016 PBAC meeting is now available. ...
Posted by Michael Wonder on 28 Apr 2016
PBAC to consider first submission for a cellular therapy in July
28 April 2016 - The PBAC will consider a major submission from Amgen for talimogene laherparepvec (Imlygic) at its next scheduled ...